Depletion of vasoactive intestinal peptide and substance P in parotid glands of atropinized rats during reflex secretion.
Rats previously starved for 30 h were offered hard chow over a period of 80 min, and the effect of eating on the parotid gland content of vasoactive intestinal peptide (VIP), substance P and neuropeptide Y (NPY) was examined. In rats pretreated with I.P. atropine and alpha- and beta-adrenoceptor blocking agents, the total amounts of VIP and substance P were reduced after feeding by 23 and 42%, respectively; in contrast the NPY content was not significantly affected. Similarly, in animals given atropine alone the VIP content was reduced by 25% and substance P by 40% after feeding. In the absence of autonomic receptor blockade, there was no loss of parotid neuropeptide content in response to feeding. Neither an intact sympathetic innervation nor a capsaicin-sensitive sensory innervation was a prerequisite for depletion of parotid neuropeptides in the presence of atropine and adrenoceptor blockers. The observed decrease in neuropeptide content is thought to reflect an imbalance between peptide release from nerve terminals and their replenishment by axonal transport, this imbalance resulting from the unusually high demands on the parasympathetic non-adrenergic, non-cholinergic (NANC) mechanism. Under normal conditions salivary peptidergic mechanisms are spared as seen in the absence of autonomic receptor blockade.
Asztély
A
A
Department of Pharmacology, Göteborg University, Sweden.
Ekman
R
R
Tobin
G
G
Ekström
J
J
D018674:Adrenergic Antagonists / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001835:Body Weight; D002211:Capsaicin / Q000494:pharmacology; D004032:Diet; D005260:Female; D009478:Neuropeptide Y / Q000378:metabolism; D009929:Organ Size; D010306:Parotid Gland / Q000378:metabolism*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012018:Reflex / Q000502:physiology; D013373:Substance P / Q000378:metabolism*; D013562:Sympathectomy; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism*
D018674:Adrenergic Antagonists; D009478:Neuropeptide Y; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D001285:Atropine; D011433:Propranolol; D002211:Capsaicin; D010646:Phentolamine